Cargando…
Precision Oncology Comes of Age: Tumor-Agnostic Approaches
Colleen Lewis, MSN, ANP-BC, AOCNP®, and R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, presented on the new world of tumor-agnostic treatment approaches, including those aimed at managing patients with tumors that have high microsatellite instability (MSI-H) or neurotrophic receptor tyrosine kinase (N...
Autores principales: | Lewis, Colleen, Harvey, R. Donald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857330/ https://www.ncbi.nlm.nih.gov/pubmed/33598315 http://dx.doi.org/10.6004/jadpro.2020.11.3.2 |
Ejemplares similares
-
MGED comes of age
por: Causton, Helen C, et al.
Publicado: (2003) -
Caenorhabditis elegans comes of age
por: Ceron, Julian, et al.
Publicado: (2008) -
Comparative genomics comes of age
por: Lipovich, Leonard
Publicado: (2002) -
Precision medicine becomes reality—tumor type-agnostic therapy
por: Yan, Li, et al.
Publicado: (2018) -
Coming of age of personalized medicine: challenges ahead
por: Borry, Pascal
Publicado: (2009)